CCNL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.234400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.193600E-01
Normal-vs-Stage2
4.427600E-01
Normal-vs-Stage3
3.254800E-01
Normal-vs-Stage4
4.617200E-01
Stage1-vs-Stage2
8.016600E-01
Stage1-vs-Stage3
2.107000E-01
Stage1-vs-Stage4
6.980800E-01
Stage2-vs-Stage3
2.623600E-01
Stage2-vs-Stage4
9.335800E-01
Stage3-vs-Stage4
2.160000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.267200E-01
Normal-vs-AfricanAmerican
1.841230E-01
Normal-vs-Asian
4.279600E-01
Caucasian-vs-AfricanAmerican
6.563000E-01
Caucasian-vs-Asian
9.232800E-01
AfricanAmerican-vs-Asian
7.884800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.217400E-01
Normal-vs-Female
4.282400E-01
Male-vs-Female
8.605600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.301200E-01
Normal-vs-Age(41-60Yrs)
4.927000E-01
Normal-vs-Age(61-80Yrs)
3.990800E-01
Normal-vs-Age(81-100Yrs)
3.708000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.774400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.319000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.334400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.925900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.877840E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.661000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.162200E-01
Normal-vs-Daily Drinker
4.136200E-01
Normal-vs-Weekly Drinker
3.726200E-01
Normal-vs-Occasional Drinker
4.548600E-01
Normal-vs-Social Drinker
4.365800E-01
Non Drinker-vs-Daily Drinker
9.671200E-01
Non Drinker-vs-Weekly Drinker
5.069000E-01
Non Drinker-vs-Occasional Drinker
6.353200E-01
Non Drinker-vs-Social Drinker
8.299200E-01
Daily Drinker-vs-Weekly Drinker
5.038000E-01
Daily Drinker-vs-Occasional Drinker
6.100000E-01
Daily Drinker-vs-Social Drinker
8.012600E-01
Weekly Drinker-vs-Occasional Drinker
3.266800E-01
Weekly Drinker-vs-Social Drinker
4.564400E-01
Occasional Drinker-vs-Social Drinker
8.430000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.693970E-01
Normal-vs-Grade 2
1.414200E-02
Normal-vs-Grade 3
3.263800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.503980E-02
Grade 1-vs-Grade 3
4.160400E-02
Grade 1-vs-Grade 4
1.693970E-01
Grade 2-vs-Grade 3
9.115400E-01
Grade 2-vs-Grade 4
1.414200E-02
Grade 3-vs-Grade 4
3.263800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.843600E-01
Normal-vs-NonDiabetic
4.317600E-01
Diabetic-vs-NonDiabetic
2.609200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.899800E-01
Normal-vs-NoPancreatitis
4.087800E-01
Pancreatitis-vs-NoPancreatitis
3.109600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.018800E-01
Normal-vs-N1
4.328000E-01
N0-vs-N1
4.183600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.960200E-01
Normal-vs-TP53-NonMutant
3.427600E-01
TP53-Mutant-vs-TP53-NonMutant
2.723200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
